NCT03920332View on ClinicalTrials.gov

Pregnancy and Fibrinogen Disorders

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Hypofibrinogenemia, CongenitalAfibrinogenemia, CongenitalDysfibrinogenemia, Congenital
Trial Locations (3)

75014

Hopital Port-Royal, Paris

03659

Jessenius Faculty of Medicine and University Hospital, Martin

Unknown

University Hospitals of Geneva, Geneva

All Listed Sponsors
collaborator

Swiss Hemophilia Network

OTHER

lead

University Hospital, Geneva

OTHER

NCT03920332 - Pregnancy and Fibrinogen Disorders | Biotech Hunter | Biotech Hunter